180 Life Sciences Corp (ATNF)
3.43
-0.31
(-8.29%)
USD |
NASDAQ |
Nov 04, 16:00
3.45
+0.02
(+0.58%)
After-Hours: 20:00
180 Life Sciences Total Assets (Quarterly): 3.911M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 3.911M |
| March 31, 2024 | 3.442M |
| December 31, 2023 | 5.260M |
| September 30, 2023 | 4.958M |
| June 30, 2023 | 13.67M |
| March 31, 2023 | 14.92M |
| December 31, 2022 | 19.65M |
| September 30, 2022 | 34.34M |
| Date | Value |
|---|---|
| June 30, 2022 | 53.36M |
| March 31, 2022 | 59.68M |
| December 31, 2021 | 62.71M |
| September 30, 2021 | 65.07M |
| June 30, 2021 | 56.27M |
| March 31, 2021 | 60.11M |
| December 31, 2020 | 55.53M |
| December 31, 2019 | 51.88M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
3.442M
Minimum
Mar 2024
65.07M
Maximum
Sep 2021
35.30M
Average
43.11M
Median
Total Assets (Quarterly) Benchmarks
| Seelos Therapeutics Inc | 2.381M |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 10.74M |
| iBio Inc | 28.73M |
| Theriva Biologics Inc | 42.39M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.329M |
| Shareholders Equity (Quarterly) | -0.418M |